Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
about
Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domainsCul4A is required for hematopoietic stem-cell engraftment and self-renewalCul4A is required for hematopoietic cell viability and its deficiency leads to apoptosisErythropoietic defect associated with reduced cell proliferation in mice lacking the 26S proteasome shuttling factor Rad23b.Carfilzomib in multiple myeloma.
P2860
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
@ast
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
@en
type
label
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
@ast
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
@en
prefLabel
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
@ast
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
@en
P2093
P2860
P356
P1433
P1476
Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
@en
P2093
Marteijn JA
van der Reijden BA
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404319
P577
2006-07-27T00:00:00Z